PubMed

Reduced mortality associated with the use of ACE inhibitors in patients with type 2 diabetes.

Eurich DT, Majumdar SR, Tsuyuki RT, Johnson JA.

Diabetes Care. 2004 Jun;27(6):1330-4.PMID: 15161784 [PubMed - indexed for MEDLINE]Related articlesFree article

Effect of angiotensin-converting enzyme inhibition on survival in 3773 Chinese type 2 diabetic patients.

So WY, Ozaki R, Chan NN, Tong PC, Ho CS, Lam CW, Ko GT, Chow CC, Chan WB, Ma RC, Chan JC.

Hypertension. 2004 Sep;44(3):294-9. Epub 2004 Jul 12.PMID: 15249544 [PubMed - indexed for MEDLINE]Related articlesFree article

Atrial fibrillation and morbidity and mortality in a cohort of long-term hemodialysis patients.

Genovesi S, Vincenti A, Rossi E, Pogliani D, Acquistapace I, Stella A, Valsecchi MG.

Am J Kidney Dis. 2008 Feb;51(2):255-62.PMID: 18215703 [PubMed - indexed for MEDLINE]Related articles

Improved clinical outcomes associated with metformin in patients with diabetes and heart failure.

Eurich DT, Majumdar SR, McAlister FA, Tsuyuki RT, Johnson JA.

Diabetes Care. 2005 Oct;28(10):2345-51.PMID: 16186261 [PubMed - indexed for MEDLINE]Related articlesFree article

The effectiveness of beta-blockers after myocardial infarction in patients with type 2 diabetes.

McDonald CG, Majumdar SR, Mahon JL, Johnson JA.

Diabetes Care. 2005 Sep;28(9):2113-7.PMID: 16123475 [PubMed - indexed for MEDLINE]Related articlesFree article

Effect of metformin-containing antidiabetic regimens on all-cause mortality in veterans with type 2 diabetes mellitus.

Gosmanova EO, Canada RB, Mangold TA, Rawls WN, Wall BM.

Am J Med Sci. 2008 Sep;336(3):241-7.PMID: 18794619 [PubMed - indexed for MEDLINE]Related articles

Decreased mortality associated with the use of metformin compared with sulfonylurea monotherapy in type 2 diabetes.

Johnson JA, Majumdar SR, Simpson SH, Toth EL.

Diabetes Care. 2002 Dec;25(12):2244-8.PMID: 12453968 [PubMed - indexed for MEDLINE]Related articlesFree article

Evidence of suboptimal management of cardiovascular risk in patients with type 2 diabetes mellitus and symptomatic atherosclerosis.

Brown LC, Johnson JA, Majumdar SR, Tsuyuki RT, McAlister FA.

CMAJ. 2004 Nov 9;171(10):1189-92.PMID: 15534311 [PubMed - indexed for MEDLINE]Related articlesFree article

Retrospective longitudinal cohort study comparing the effects of angiotensin-converting enzyme inhibitors and long-acting calcium channel blockers on total and cardiovascular mortality in patients with hypertension.

Tardif JC, Ducharme A, Yu H, Wogen J, Guertin MC.

Clin Ther. 2004 Jul;26(7):1073-83.PMID: 15336472 [PubMed - indexed for MEDLINE]Related articles

Association between cardiovascular outcomes and antihypertensive drug treatment in older women.

Wassertheil-Smoller S, Psaty B, Greenland P, Oberman A, Kotchen T, Mouton C, Black H, Aragaki A, Trevisan M.

JAMA. 2004 Dec 15;292(23):2849-59. Erratum in: JAMA. 2005 Apr 6;293(13):1594. PMID: 15598916 [PubMed - indexed for MEDLINE]Related articlesFree article

Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin.

Bowker SL, Majumdar SR, Veugelers P, Johnson JA.

Diabetes Care. 2006 Feb;29(2):254-8.PMID: 16443869 [PubMed - indexed for MEDLINE]Related articlesFree article

Angiotensin-converting enzyme (ACE) inhibition in type 2, diabetic patients-- interaction with ACE insertion/deletion polymorphism.

So WY, Ma RC, Ozaki R, Tong PC, Ng MC, Ho CS, Lam CW, Chow CC, Chan WB, Kong AP, Chan JC.

Kidney Int. 2006 Apr;69(8):1438-43.PMID: 16395257 [PubMed - indexed for MEDLINE]Related articles

Effect of a multifactorial intervention on mortality in type 2 diabetes.

Gaede P, Lund-Andersen H, Parving HH, Pedersen O.

N Engl J Med. 2008 Feb 7;358(6):580-91.PMID: 18256393 [PubMed - indexed for MEDLINE]Related articlesFree article

Pharmacoeconomic analysis of angiotensin-converting enzyme inhibitors in type 2 diabetes: a Markov model.

Campbell HM, Boardman KD, Dodd MA, Raisch DW.

Ann Pharmacother. 2007 Jul;41(7):1101-10. Epub 2007 Jul 3.PMID: 17609233 [PubMed - indexed for MEDLINE]Related articles

Antihypertensive therapy and incidence of type 2 diabetes in an elderly cohort.

Padwal R, Mamdani M, Alter DA, Hux JE, Rothwell DM, Tu K, Laupacis A.

Diabetes Care. 2004 Oct;27(10):2458-63.PMID: 15451916 [PubMed - indexed for MEDLINE]Related articlesFree article

Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?

Weir MR.

Clin Ther. 2007 Sep;29(9):1803-24. Review.PMID: 18035185 [PubMed - indexed for MEDLINE]Related articles

Systematic review on urine albumin testing for early detection of diabetic complications.

Newman DJ, Mattock MB, Dawnay AB, Kerry S, McGuire A, Yaqoob M, Hitman GA, Hawke C.

Health Technol Assess. 2005 Aug;9(30):iii-vi, xiii-163. Review.PMID: 16095545 [PubMed - indexed for MEDLINE]Related articlesFree article

Cost-effectiveness of full medicare coverage of angiotensin-converting enzyme inhibitors for beneficiaries with diabetes.

Rosen AB, Hamel MB, Weinstein MC, Cutler DM, Fendrick AM, Vijan S.

Ann Intern Med. 2005 Jul 19;143(2):89-99.PMID: 16027450 [PubMed - indexed for MEDLINE]Related articlesFree article

Medication nonadherence is associated with a broad range of adverse outcomes in patients with coronary artery disease.

Ho PM, Magid DJ, Shetterly SM, Olson KL, Maddox TM, Peterson PN, Masoudi FA, Rumsfeld JS.

Am Heart J. 2008 Apr;155(4):772-9.PMID: 18371492 [PubMed - indexed for MEDLINE]Related articles

Effect of ACE and AT-2 inhibitors on mortality and progression to microalbuminuria in a nested case-control study of diabetic nephropathy in diabetes mellitus type 2: results from the GENDIAN study.

Böger CA, Haak T, Götz AK, Christ J, Ruff E, Hoffmann U, Riegger GA, Krämer BK.

Int J Clin Pharmacol Ther. 2006 Aug;44(8):364-74.PMID: 16961167 [PubMed - indexed for MEDLINE]Related articles